• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Progress towards molecular patient stratification of hepatocellular carcinoma: Lost in translation?

作者信息

Chiang Derek Y, Villanueva Augusto

机构信息

Novartis Institutes for Biomedical Research, Cambridge, MA, USA.

Division of Liver Diseases, Department of Medicine, Liver Cancer Program, Tisch Cancer Institute, Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Division of Hematology and Medical Oncology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

出版信息

J Hepatol. 2017 Nov;67(5):893-895. doi: 10.1016/j.jhep.2017.07.031. Epub 2017 Aug 31.

DOI:10.1016/j.jhep.2017.07.031
PMID:28837834
Abstract
摘要

相似文献

1
Progress towards molecular patient stratification of hepatocellular carcinoma: Lost in translation?肝细胞癌分子患者分层研究进展：翻译中迷失了？
J Hepatol. 2017 Nov;67(5):893-895. doi: 10.1016/j.jhep.2017.07.031. Epub 2017 Aug 31.
2
Immunotherapy of hepatocellular carcinoma.肝细胞癌的免疫治疗
J Hepatol. 2006 Dec;45(6):868-78. doi: 10.1016/j.jhep.2006.09.004. Epub 2006 Sep 29.
3
Molecular Profiling and Research of Therapeutic Targets.治疗靶点的分子剖析与研究
Dig Dis. 2015;33(4):586-9. doi: 10.1159/000375347. Epub 2015 Jul 6.
4
[Molecular pathogenesis of hepatocellular carcinoma].
Nihon Shokakibyo Gakkai Zasshi. 2011 Aug;108(8):1347-53.
5
[Immunogenetic studies on etiology of liver disease --HLA and primary hepatoma (author's transl)].肝脏疾病病因的免疫遗传学研究——人类白细胞抗原与原发性肝癌（作者译）
Igaku Kenkyu. 1979 Sep;49(3):247-8.
6
[Expression of HLA-I antigens in primary hepatocellular carcinoma].[原发性肝细胞癌中HLA-I抗原的表达]
Hua Xi Yi Ke Da Xue Xue Bao. 2001 Dec;32(4):495-6, 504.
7
Strategies for HCC target discovery.肝癌靶点发现策略。
Aging (Albany NY). 2017 Apr;9(4):1088-1089. doi: 10.18632/aging.101233.
8
[Co-transfection of staphylococcal enterotoxin A and B7.1 into human hepatocellular carcinoma cells and analysis of their immunological effect].[葡萄球菌肠毒素A与B7.1共转染人肝癌细胞及其免疫效应分析]
Zhonghua Gan Zang Bing Za Zhi. 2003 Jun;11(6):375.
9
Cancer stem cells in hepatocellular carcinomas.肝细胞癌中的癌症干细胞。
Indian J Med Res. 2015 Oct;142(4):362-5. doi: 10.4103/0971-5916.169191.
10
Mutation of p53 gene in hepatocellular carcinoma in Taiwan.
Cancer Res. 1992 Nov 1;52(21):6098-100.

引用本文的文献

1
Global DNA hypermethylation pattern and unique gene expression signature in liver cancer from patients with Indigenous American ancestry.美洲原住民血统患者肝癌中的全基因组DNA高甲基化模式及独特基因表达特征
Oncotarget. 2021 Mar 2;12(5):475-492. doi: 10.18632/oncotarget.27890.
2
Anti-GPC3 Antibody Tagged Cationic Switchable Lipid-Based Nanoparticles for the Co-Delivery of Anti-miRNA27a And Sorafenib in Liver Cancers.抗 GPC3 抗体标记的阳离子可切换脂质基纳米粒用于肝癌中抗 miRNA27a 和索拉非尼的共递送。
Pharm Res. 2019 Aug 8;36(10):145. doi: 10.1007/s11095-019-2669-5.
3
New prognostic biomarkers of mortality in patients undergoing liver transplantation for hepatocellular carcinoma.
肝细胞癌患者行肝移植术后死亡率的新预后生物标志物。
World J Gastroenterol. 2018 Oct 7;24(37):4230-4242. doi: 10.3748/wjg.v24.i37.4230.
4
Anti-GPC3 antibody-modified sorafenib-loaded nanoparticles significantly inhibited HepG2 hepatocellular carcinoma.载有索拉非尼的抗 GPC3 抗体修饰纳米颗粒显著抑制 HepG2 肝癌。
Drug Deliv. 2018 Nov;25(1):1484-1494. doi: 10.1080/10717544.2018.1477859.